StockNews.com upgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a hold rating to a buy rating in a report issued on Friday morning. A number of other research firms have also issued reports on ALNY. Morgan Stanley reduced their price target on shares of Alnylam Pharmaceuticals from $184.00 to $176.00 and set an […]
Wellington Management Group LLP grew its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 6.0% during the third quarter, Holdings Channel.com reports. The institutional investor owned 6,431,814 shares of the biopharmaceutical company’s stock after purchasing an additional 364,021 shares during the quarter. Wellington Management Group LLP owned 0.05% of Alnylam Pharmaceuticals […]
Wellington Management Group LLP Purchases 364,021 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Karani Asset Management LLC lessened its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 24.2% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,555 shares of the biopharmaceutical company’s stock after selling 3,690 shares during the quarter. Alnylam Pharmaceuticals comprises […]
StockNews.com downgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a strong-buy rating to a buy rating in a report published on Wednesday. A number of other research analysts have also recently commented on ALNY. William Blair restated an outperform rating on shares of Alnylam Pharmaceuticals in a research note on Monday, January 8th. […]